Marshall Wace, LLP Voyager Therapeutics, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.15 - $10.84 $192,585 - $291,975	-26,935 Reduced 36.04%	47,808 $445,000
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $840,383 - $1.18 Million	-133,819 Reduced 64.16%	74,743 $630,000
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $1.97 Million - $2.93 Million	-260,715 Reduced 55.56%	208,562 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $2.79 Million - $5.63 Million	402,280 Added 600.44%	469,277 $5.37 Million
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $401,982 - $722,227	66,997 New	66,997 $516,000
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $1.06 Million - $1.42 Million	189,736 New	189,736 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $1.47 Million - $3.08 Million	-305,445 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.75 - $9.44 $375,199 - $1.29 Million	-136,436 Reduced 30.88%	305,445 $2.33 Million
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $1.04 Million - $2.33 Million	420,029 Added 1922.15%	441,881 $1.2 Million
Q2 2021 Aug 13, 2021	SELL	$3.94 - $5.44 $42,721 - $58,985	-10,843 Reduced 33.16%	21,852 $90,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $150,723 - $295,562	32,695 New	32,695 $154,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $960,499 - $1.32 Million	-95,954 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$8.05 - $14.21 $792,844 - $1.4 Million	-98,490 Reduced 50.65%	95,954 $1.21 Million
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $1.32 Million - $2.85 Million	194,444 New	194,444 $1.78 Million
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $540,247 - $710,075	-42,141 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $687,319 - $1.19 Million	42,141 New	42,141 $725,000
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $504,653 - $1.06 Million	-58,749 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $1.01 Million - $1.28 Million	58,749 New	58,749 $1.11 Million

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$30.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.1 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.6 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18.4 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.2 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account